Assessing the quality of life of people with diabetes in a hospital in Takoradi-Ghana
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20222898Keywords:
Diabetes, Quality of life, Treatment satisfaction, Physical function, Psychological functionAbstract
Background: Persons living with diabetes have been shown to have a significant negative impact on both their physical and mental wellbeing. This study sought to determine the quality of life of people with diabetes.
Methods: A descriptive study was used for this study. A convenient sampling technique was employed to recruit 100 participants at the Nagel Adventist Memorial hospital in Ghana. The instrument that was used to collect data from participants was a questionnaire adopted from the MDQoL-17 questionnaire.
Results: The study showed that a majority of the participants 60% indicated that, they were very satisfied with their treatment at NMAH. In addition, 36% indicated they were moderately satisfied and just 4% indicated they were not satisfied with the treatment at all. Seventy- eight percent (78%) representing the majority of participants indicated they get physically ill and had poor physical functions. A p value of 0.428 was recorded for an association between gender and treatment satisfaction with a Cramer V value of 0.148.
Conclusions: The study found no significant association between gender, age and quality of life. Also, the participants recruited was found to have a poor quality of life. The study therefore suggests that Stakeholders and Ministry of Health should subsidize the cost of treatment or even make diabetes medications free to enable everybody get access to it and also health facilities should inculcate physical and psychological training into their diabetes education to help improve patients’ quality of life.
Metrics
References
Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed on 20 October 2021.
Saklayen M. The global epidemic of the metabolic syndrome. Curr Hyperten Rep. 2018;20(2):21-9.
Boutayeb A, Boutayeb S, Boutayeb W. Multi-morbidity of non-communicable diseases and equity in WHO Eastern Mediterranean countries. Int J Equity Health. 2013;12(1):60.
Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed on 20 October 2021.
Al-Lawati JA. Diabetes mellitus: a local and global public health emergency!. Oman Med J. 2017;32(3): 177.
Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018;14(6): 491-509.
Ediriweera DS, Karunapema P, Pathmeswaran A, Arnold M. Increase in premature mortality due to non-communicable diseases in Sri Lanka during the first decade of the twenty-first century. BMC Public Health. 2018;18(1):1-6.
Zimmermann M, Bunn C, Namadingo H, Gray CM, Lwanda J. Experiences of type 2 diabetes in sub-Saharan Africa: a scoping review. Global Health Res Policy. 2018;3(1):1-3.
Diabetes. Available at: https://www.scirp.org/ reference/ReferencesPapers.aspx?ReferenceID=1559405. Accessed on 20 October 2021.
Wattana C, Srisuphan W, Pothiban L, Upchurch SL. Effects of a diabetes self‐management program on glycemic control, coronary heart disease risk, and quality of life among Thai patients with type 2 diabetes. Nurs Health Sci. 2007;9(2):135-41.
Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, Gray LJ, et al. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Family Pract. 2012;13(1):1-0.
Vuletić G, Misajon R. Subjective quality of life: historical review. Quality Life Health. 2011:9-16.
Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004;61(5):679-86.
Opara PI, Jaja T, Onubogu UC. Morbidity and mortality amongst infants of diabetic mothers admitted into a special care baby unit in Port Harcourt, Nigeria. Italian J Pediatr. 2010;36(1):1-6.
Spasić A, Radovanović R, Đorđević A, Stefanović N, Cvetković T. Quality of life in type 2 diabetic patients. Acta Facult Med Naissensis. 2014;31(3): 193-200.
Prajapati VB, Blake R, Acharya LD, Seshadri S. Assessment of quality of life in type II diabetic patients using the modified diabetes quality of life (MDQoL)-17 questionnaire. Br J Pharma Sci. 2018; 5:53.
Tortora RD. A note on sample size estimation for multinomial populations. Am Statistic. 1963;32(3): 100-2.
Prajapati VB, Blake R, Acharya LD, Seshadri S. Assessment of quality of life in type II diabetic patients using the modified diabetes quality of life (MDQoL)-17 questionnaire. Br J Pharma Sci. 2018; 5:53.
Abazari P, Vanaki Z, Mohammadi E, Amini M. Inadequate investment on management of diabetes education. J Res Med Sci. 2012;17(8):792.
Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, et al. Effectiveness of community health workers in the care of persons with diabetes. Diab Med. 2006;23(5):544-56.
Al-Aujan S, Al-Aqeel S, Al-Harbi A, Al-Abdulltif E. Patients’ satisfaction with diabetes medications in one hospital, Saudi Arabia. Patient Pref Adhere. 2012;6:735.
Biderman A, Noff E, Harris SB, Friedman N, Levy A. Treatment satisfaction of diabetic patients: what are the contributing factors?. Family Pract. 2009;26(2):102-8.
Ghosh A, Anjana RM, Rani CS, Rani SJ, Gupta R, Jha A, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diab Metab Synd: Clin Res Rev. 2021;15(1):215-20.
Bhatt SP, Misra A, Pandey RM, Upadhyay AD, Gulati S, Singh N. Vitamin D supplementation in overweight/obese Asian Indian women with prediabetes reduces glycemic measures and truncal subcutaneous fat: a 78 weeks randomized placebo-controlled trial. Sci Rep. 2020;10(1):1-3.
Wang L, Li X, Wang Z, Bancks MP, Carnethon MR, Greenland P, et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018. JAMA. 2021;326(8):704-16.
Adeyege CB, Awotidebe TO, Fasakin OM, Afolabi TO, Adedoyin RA. Associations between physical functioning and psychosocial factors in patients with type-2 diabetes mellitus. Int J Diabetes Clin Res. 2021;8:136.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diab Care. 2008;31(12):2383-90.
Chima CC, Salemi JL, Wang M, de Grubb MC, Gonzalez SJ, Zoorob RJ. Multimorbidity is associated with increased rates of depression in patients hospitalized with diabetes mellitus in the United States. J Diab Complicat. 2017;31(11):1571-9.
Cherrington A, Wallston KA, Rothman RL. Exploring the relationship between diabetes self-efficacy, depressive symptoms, and glycemic control among men and women with type 2 diabetes. J Behav Med. 2010;33(1):81-9.
Musselman DL, Ziemer DC, McNutt MD, Seay JS, Royster EB, Larsen B, et al. Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res. 2014;52:21-7.
Degu H, Wondimagegnehu A, Yifru YM, Belachew A. Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia?. PloS One. 2019; 14(2):e0211449.
Venkataraman K, Wee HL, Leow MK, Tai ES, Lee J, Lim SC, et al. Associations between complications and health‐related quality of life in individuals with diabetes. Clin Endocrinol. 2013;78(6):865-73.
